In order to ensure appropriate market surveillance by Member States, it is necessary that manufacturers, importers and distributors operate an appropriate system for monitoring and recording suspected adverse effects and inform the competent authorities about such effects so that appropriate action can be taken. It is warranted to provide for a safeguard clause that would allow Member States to take action to address serious risks to public health.
Recital 45, Directive (EU) 2014/40
Judgment of the Court (Second Chamber) of 4 May 2016. Pillbox 38 (UK) Limited, trading as Totally Wicked v Secretary of State for Health.Decision
Recitals 7, 33, 36, 38 to 41, 43 to 45, 47 and 48 of Directive 2014/40 state: Legislative action at Union level is also necessary in order to implement the [FCTC] ..., the provisions of which are binding on the Union and its Member States. …
4 May 2016 · 62014CJ0477
Opinion of Advocate General Tanchev delivered on 15 July 2021. Pro Rauchfrei eV v JS e.K.Decision
In my view, the first sentence of recital 48 of Directive 2014/40 applies only to electronic cigarettes and refill containers, not to tobacco products such as cigarettes. [For the sake of completeness, I should specify that electronic …
15 Jul 2021 · 62020CC0370